Galina N. Tarasova

Rostov-na-donu, ROS 344022, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Effectiveness and Safety of First-Line Empirical Eradication Therapy with Rebamipide: Results from the European Registry on Helicobacter pylori Management (Hp-EuReg).

Effectiveness and Safety of First-Line Empirical Eradication Therapy with Rebamipide: Results from the European Registry on Helicobacter pylori Management (Hp-EuReg).

Journal: Antibiotics (Basel, Switzerland)

Published: April 15, 2026

Higher doses of Bismuth and antibiotics do not improve H. pylori treatment effectiveness: results from the Hp-EuReg.

Higher doses of Bismuth and antibiotics do not improve H. pylori treatment effectiveness: results from the Hp-EuReg.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: November 18, 2025

Higher Doses of Bismuth and Antibiotics Do Not Improve Helicobacter pylori Treatment Effectiveness: Results From the European Registry on Helicobacter pylori Management.

Higher Doses of Bismuth and Antibiotics Do Not Improve Helicobacter pylori Treatment Effectiveness: Results From the European Registry on Helicobacter pylori Management.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: November 18, 2025

Effectiveness of empirical Helicobacter pylori eradication therapy with furazolidone in Russia: results from the European Registry on Helicobacter pylori Management (Hp-EuReg)

Effectiveness of empirical Helicobacter pylori eradication therapy with furazolidone in Russia: results from the European Registry on Helicobacter pylori Management (Hp-EuReg)

Journal: Terapevticheskii arkhiv

Published: March 29, 2023

Epithelial protective therapy in comorbid diseases. Practical Guidelines for Physicians

Epithelial protective therapy in comorbid diseases. Practical Guidelines for Physicians

Journal: Terapevticheskii arkhiv

Published: April 25, 2022

Multicenter study of gastroesophageal reflux disease symptoms prevalence in outpatients in Russia

Multicenter study of gastroesophageal reflux disease symptoms prevalence in outpatients in Russia

Journal: Terapevticheskii arkhiv

Published: March 11, 2022

Prevalence of nonalcoholic fatty liver disease in outpatients in Rostov-on-Don: Regional results of the DIREG-2 study

Prevalence of nonalcoholic fatty liver disease in outpatients in Rostov-on-Don: Regional results of the DIREG-2 study

Journal: Terapevticheskii arkhiv

Published: September 17, 2016

POST-GENOMIC MEDICINE: THE DIAGNOSTIC VALUE OF PROTEOMIC ANALYSIS IN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE.

POST-GENOMIC MEDICINE: THE DIAGNOSTIC VALUE OF PROTEOMIC ANALYSIS IN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE.

Journal: Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology

Published: January 01, 2016

Showing 1-8 of 8

Last Updated: 09/26/2026